ArticleCancer management and research2020

Knockdown of ATAD2 Inhibits Proliferation and Tumorigenicity Through the Rb-E2F1 Pathway and Serves as a Novel Prognostic Indicator in Gastric Cancer.

Xuan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.